Literature DB >> 23154166

Amyloid formation in heterogeneous environments: islet amyloid polypeptide glycosaminoglycan interactions.

Hui Wang1, Ping Cao, Daniel P Raleigh.   

Abstract

Amyloid formation plays an important role in a broad range of diseases, and the search for amyloid inhibitors is an active area of research. Amyloid formation takes places in a heterogeneous environment in vivo with the potential for interactions with membranes and with components of the extracellular matrix. Naturally occurring amyloid deposits are associated with sulfated proteoglycans and other factors. However, the vast majority of in vitro assays of amyloid formation and amyloid inhibition are conducted in homogeneous solution where the potential for interactions with membranes or sulfated proteoglycans is lacking and it is possible that different results may be obtained in heterogeneous environments. We show that variants of islet amyloid polypeptide (IAPP), which are non-amyloidogenic in homogeneous solution, can be readily induced to form amyloid in the presence of glycosaminoglycans (GAGs). GAGs are found to be more effective than anionic lipid vesicles at inducing amyloid formation on a per-charge basis. Several known inhibitors of IAPP amyloid formation are shown to be less effective in the presence of GAGs.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23154166      PMCID: PMC3753189          DOI: 10.1016/j.jmb.2012.11.003

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  61 in total

1.  Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis.

Authors:  Shae B Padrick; Andrew D Miranker
Journal:  Biochemistry       Date:  2002-04-09       Impact factor: 3.162

Review 2.  Basement membrane and beta amyloid fibrillogenesis in Alzheimer's disease.

Authors:  S Inoue
Journal:  Int Rev Cytol       Date:  2001

3.  Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols.

Authors:  Ping Cao; Daniel P Raleigh
Journal:  Biochemistry       Date:  2012-03-21       Impact factor: 3.162

4.  Protein folding and misfolding: a paradigm of self-assembly and regulation in complex biological systems.

Authors:  Michele Vendruscolo; Jesús Zurdo; Cait E MacPhee; Christopher M Dobson
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2003-06-15       Impact factor: 4.226

5.  Ionic strength effects on amyloid formation by amylin are a complicated interplay among Debye screening, ion selectivity, and Hofmeister effects.

Authors:  Peter J Marek; Vadim Patsalo; David F Green; Daniel P Raleigh
Journal:  Biochemistry       Date:  2012-10-16       Impact factor: 3.162

6.  Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation.

Authors:  K Park; C B Verchere
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

7.  Proteoglycans synthesized and secreted by pancreatic islet beta-cells bind amylin.

Authors:  Susan Potter-Perigo; Rebecca L Hull; Christina Tsoi; Kathleen R Braun; Sofianos Andrikopoulos; Jeanette Teague; C Bruce Verchere; Steven E Kahn; Thomas N Wight
Journal:  Arch Biochem Biophys       Date:  2003-05-15       Impact factor: 4.013

Review 8.  Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit.

Authors:  John B Ancsin
Journal:  Amyloid       Date:  2003-06       Impact factor: 7.141

Review 9.  Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders.

Authors:  Jack van Horssen; Pieter Wesseling; Lambert P W J van den Heuvel; Robert M W de Waal; Marcel M Verbeek
Journal:  Lancet Neurol       Date:  2003-08       Impact factor: 44.182

Review 10.  Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.

Authors:  Marina D Kirkitadze; Gal Bitan; David B Teplow
Journal:  J Neurosci Res       Date:  2002-09-01       Impact factor: 4.164

View more
  10 in total

1.  Sulfate anion delays the self-assembly of human insulin by modifying the aggregation pathway.

Authors:  Marta Owczarz; Paolo Arosio
Journal:  Biophys J       Date:  2014-07-01       Impact factor: 4.033

2.  Islet Amyloid Polypeptide Membrane Interactions: Effects of Membrane Composition.

Authors:  Xiaoxue Zhang; Johnna R St Clair; Erwin London; Daniel P Raleigh
Journal:  Biochemistry       Date:  2017-01-05       Impact factor: 3.162

3.  Extracellular vesicles from human pancreatic islets suppress human islet amyloid polypeptide amyloid formation.

Authors:  Diana Ribeiro; Istvan Horvath; Nikki Heath; Ryan Hicks; Anna Forslöw; Pernilla Wittung-Stafshede
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-02       Impact factor: 11.205

4.  The ability of insulin to inhibit the formation of amyloid by pro-islet amyloid polypeptide processing intermediates is significantly reduced in the presence of sulfated glycosaminoglycans.

Authors:  Hui Wang; Daniel P Raleigh
Journal:  Biochemistry       Date:  2014-04-18       Impact factor: 3.162

5.  Heparan sulfates facilitate harmless amyloidogenic fibril formation interacting with elastin-like peptides.

Authors:  Federica Boraldi; Pasquale Moscarelli; Brigida Bochicchio; Antonietta Pepe; Anna M Salvi; Daniela Quaglino
Journal:  Sci Rep       Date:  2018-02-15       Impact factor: 4.379

6.  Epigallocatechin-3-gallate remodels apolipoprotein A-I amyloid fibrils into soluble oligomers in the presence of heparin.

Authors:  David Townsend; Eleri Hughes; Geoffrey Akien; Katie L Stewart; Sheena E Radford; David Rochester; David A Middleton
Journal:  J Biol Chem       Date:  2018-05-31       Impact factor: 5.157

Review 7.  Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide Amyloidogenesis.

Authors:  Phuong Trang Nguyen; Nagore Andraka; Carole Anne De Carufel; Steve Bourgault
Journal:  J Diabetes Res       Date:  2015-10-20       Impact factor: 4.011

8.  Effect of Phosphatidylserine and Cholesterol on Membrane-mediated Fibril Formation by the N-terminal Amyloidogenic Fragment of Apolipoprotein A-I.

Authors:  Chiharu Mizuguchi; Mitsuki Nakamura; Naoko Kurimitsu; Takashi Ohgita; Kazuchika Nishitsuji; Teruhiko Baba; Akira Shigenaga; Toshinori Shimanouchi; Keiichiro Okuhira; Akira Otaka; Hiroyuki Saito
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

Review 9.  The effect of glycosaminoglycans (GAGs) on amyloid aggregation and toxicity.

Authors:  Clara Iannuzzi; Gaetano Irace; Ivana Sirangelo
Journal:  Molecules       Date:  2015-02-02       Impact factor: 4.411

10.  The small molecule inhibitor anle145c thermodynamically traps human islet amyloid peptide in the form of non-cytotoxic oligomers.

Authors:  Manikam S Saravanan; Sergey Ryazanov; Andrei Leonov; Janine Nicolai; Patrique Praest; Armin Giese; Roland Winter; Lucie Khemtemourian; Christian Griesinger; J Antoinette Killian
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.